Crossmark Global Holdings Inc. Sells 753 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Crossmark Global Holdings Inc. cut its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 3.3% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 22,245 shares of the healthcare conglomerate’s stock after selling 753 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in UnitedHealth Group were worth $11,253,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Kathleen S. Wright Associates Inc. purchased a new position in UnitedHealth Group during the third quarter worth about $27,000. Global Wealth Strategies & Associates lifted its position in UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 32 shares during the last quarter. West Financial Advisors LLC bought a new stake in shares of UnitedHealth Group during the 3rd quarter worth $32,000. Quarry LP increased its stake in UnitedHealth Group by 132.1% in the second quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after acquiring an additional 37 shares during the last quarter. Finally, RPg Family Wealth Advisory LLC purchased a new position in shares of UnitedHealth Group during the 3rd quarter valued at about $37,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Down 0.1 %

UNH stock opened at $510.03 on Tuesday. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The firm’s fifty day simple moving average is $549.37 and its two-hundred day simple moving average is $563.70. The stock has a market capitalization of $469.37 billion, a price-to-earnings ratio of 32.91, a price-to-earnings-growth ratio of 1.39 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same period last year, the company earned $5.83 EPS. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 29.77 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.65%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Wall Street Analyst Weigh In

Several analysts have weighed in on the stock. Oppenheimer boosted their price target on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Deutsche Bank Aktiengesellschaft increased their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. Royal Bank of Canada dropped their price target on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research report on Wednesday, October 16th. Bank of America lowered their price target on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Finally, StockNews.com cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Wednesday, January 15th. Two equities research analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of $627.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.